Last reviewed · How we verify
NCT07175688
Metabolic Associated Fatty Liver Disease and Pancreatic Steatosis in Obese Versus Lean Chronic Hepatitis B Patients
trial testing Abdominal Ultrasound in Metabolic Associated Fatty Liver Disease in 217 participants. Completed in 1 January 2024.
1 January 2024
Quick facts
| Lead sponsor | Tanta University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 217 |
| Start date | 10 April 2022 |
| Primary completion | 1 January 2024 |
| Estimated completion | 1 January 2024 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Abdominal Ultrasound
- Transient elastography
- Waist Circumference
- Body mass index
Conditions studied
- Metabolic Associated Fatty Liver Disease — all drugs for Metabolic Associated Fatty Liver Disease →
- Pancreatic Steatosis — all drugs for Pancreatic Steatosis →
- Obese — all drugs for Obese →
- Lean — all drugs for Lean →
Sponsor
Tanta University
Who can join
18 and older, any sex, with Metabolic Associated Fatty Liver Disease or Pancreatic Steatosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to evaluate the prevalence of metabolic associated fatty liver disease (MAFLD), fatty pancreas and hepatic fibrosis in obese and lean patients with chronic hepatitis B; either treatment naive or on treatment with first-line nucleos(t)ide analogs.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07175688
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Abdominal Ultrasound
Trials testing the same drug.
- NCT06536933 — Study of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Sohag University Employees · not yet recruiting
- NCT04367012 — Fatty Liver Among Employees at Banha University · completed
- NCT01144507 — Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis · completed
Other recruiting trials for Metabolic Associated Fatty Liver Disease
Currently open trials in the same condition.
- NCT07246421 — Glucagon Resistance in Patients With MASLD and T2DM · NA · recruiting
- NCT07122700 — Evaluation of Non-Invasive Tests for Metabolic Liver Disease · recruiting
- NCT06883578 — Effect of Low Valine Diet on Body Weight and Metabolic Parameters · NA · recruiting
- NCT05782972 — Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot Study · Phase 4 · active not recruiting
- NCT05597709 — Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China · recruiting
Other Tanta University trials
Trials by the same sponsor.
- NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
- NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
- NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
- NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
- NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07175688 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tanta University
- Last refreshed: 16 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07175688.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing